bioRxiv2022
Avian or human influenza A viruses bind preferentially to avian- or human-type sialic acid receptors, respectively, indicating that receptor tropism is an important factor for determining the viral host range. However, there are currently no reliable methods for analyzing receptor tropism biologically under physiological conditions. Here, we established a novel system using MDCK cells with avian- or human-type sialic acid receptors and with both sialic acid receptors knocked out (KO). When we examined the replication of human and avian influenza viruses in these KO cells, we observed unique viral receptor tropism that could not be detected using a conventional solid-phase sialylglycan binding assay, which directly assesses physical binding between the virus and sialic acids. Furthermore, we serially passaged an engineered avian-derived H4N5 influenza virus, whose PB2 gene was deleted, in avian-type receptor-KO cells stably expressing PB2 to select a mutant with enhanced replication in KO cells; however, its binding to human-type sialylglycan was undetectable using the solid-phase binding assay. These data indicate that a panel of sialic acid receptor-KO cells could be a useful tool for determining the biological receptor tropism of influenza A viruses. Moreover, the PB2-KO virus experimental system could help to safely and efficiently identify the mutations required for avian influenza viruses to adapt to human cells that could trigger a new influenza pandemic. Author summaryInfluenza A virus initiates infection via hemagglutinin by binding to avian- or human-type receptors. The acquisition of mutations that allow avian virus hemagglutinins (HAs) to recognize human-type receptors is mandatory for the transmission of avian influenza viruses to humans, which could lead to a pandemic. Therefore, it is important to detect such mutation(s) in animal influenza viruses for pandemic surveillance and risk assessment. In this study, we established a novel system using a set of genetically engineered MDCK cells with knocked out sialic acid receptors to biologically evaluate the receptor tropism for influenza A viruses. Using this system, we observed unique receptor tropism in several virus strains that was undetectable using conventional solid-phase binding assays that measure physical binding between the virus and artificially synthesized sialylglycans. This study makes a significant contribution to the literature because our findings suggest the pitfall of conventional receptor binding assay and the existence of a sialic acid-independent pathway for viral infection. In addition, our system could be safely used to identify mutations that could acquire human-type receptor tropism. Thus, this system could contribute not only toward basic analyses, such as elucidating the mechanism of influenza virus host range determination, but also the surveillance of viruses of animal origin that could be capable of infecting via human-type receptors, triggering a new influenza pandemic.